What is your preferred intravesical therapy for recurrent high-grade non-muscle-invasive bladder cancer when BCG is unavailable?

If BCG is not available in standard dosing due to shortage, there are some options. First, split dosing of BCG can still be effective and have lower toxicity, so that can be considered. The SWOG study compared TICE vs Tokyo strain, and it was non-inferior, so there is hope this would be on the horiz...